IMR Press / CEOG / Volume 46 / Issue 4 / DOI: 10.12891/ceog4749.2019

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research
An observational study on diagnosis and management of adnexal masses in pregnancy
Show Less
1 Department of Obstetrics and Gynaecology, Lokmanya Tilak Municipal Medical College, Sion, Mumbai, India
*Correspondence: nnchavan22@gmail.com (N. CHAVAN)
Clin. Exp. Obstet. Gynecol. 2019, 46(4), 583–586; https://doi.org/10.12891/ceog4749.2019
Published: 10 August 2019
Abstract

Background: Adnexal masses are seen in 1 in 80 to 1 in 8,000 pregnancies. However, with an increased use of ultrasonography in pregnancy, there is a significant rise in the incidence of adnexal masses in pregnancy. Objective: The study was undertaken to analyse the incidence, histological types, complications, and management of adnexal masses in pregnancy. Materials and Methods: This is an observational study of 44 cases of adnexal masses in pregnancy, performed in the Department of Obstetrics and Gynaecology LTMMC and LTMGH, Mumbai, a tertiary reference centre, during the years 2014 to 2016. Results: The incidence of adnexal masses in pregnancy was 0.2% in this study with dermoid and mucinous cyst adenoma being the most common histological types. Torsion was the most common complication seen in the study. Only 11 (25%) cases were managed conservatively. Thirty-one cases underwent exploratory laparotomy and two were managed laparoscopically. There was no significant detrimental effect on pregnancy as 79.5% of pregnancies continued until term without any complications. Conclusion: Adnexal masses in pregnancy can be effectively managed in pregnancy. Both laparotomy and laparoscopy are safe, if used judiciously.

Keywords
Adnexal mass
Pregnancy
Laparoscopy in pregnancy
Tumour markers
Figures
Figure 1.
Share
Back to top